RecruitingNCT05013944

AnovaOS Network Powered Patient Registry

Sponsor

Anova Enterprises, Inc

Enrollment

100,000 participants

Start Date

Sep 1, 2021

Study Type

OBSERVATIONAL

Conditions

Neoplasms Diseases of the Circulatory System Infectious Disease Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)Endocrine, Nutritional and Metabolic Diseases (E00-E89)Mental and Behavioural Disorders Diseases of the Nervous System Diseases of the Eye and Adnexa Diseases of the Ear and Mastoid Process Diseases of the Respiratory System Diseases of the Digestive System Diseases of the Skin and Subcutaneous Tissue Diseases of the Musculoskeletal System and Connective Tissue Diseases of the Genitourinary System Pregnancy, Childbirth and the Puerperium Certain Conditions Originating in the Perinatal Period Congenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified Injury, Poisoning and Certain Other Consequences of External Causes External Causes of Morbidity and Mortality Factors Influencing Health Status and Contact With Health Services

Summary

The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.

Eligibility

Min Age: 18 Years

Inclusion Criteria7

years old or older;
Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative;
Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials;
Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements;
Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy;
Anticipated additional follow up with the registry once per year.
Subjects who are unable to understand the protocol or unable to provide legally effective informed consent

Interested in this trial?

Get notified about updates and connect with the research team.